Biogen Message Board - Msg: 7095538

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 156.28

+0.5%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Beltropolis Boy who wrote (827)	1/4/1999 8:51:00 AM
From: Harold Engstrom	Read Replies (2) of 1686

Not much substance there, just guesses. I don't think Jim Tobin imagined that the board would dump Jim Vincent. I think Jim Tobin probably just wanted to move on to other challenges. The decisions that will direct the company for the next few years have been made. The Avonex revenues look low as well. The analyst predicts $491MM. The revenue for last quarter was $107MM with ~51K patients. There should be another 10% increase in patients this quarter and roughly $120MM in Avonex revenues. This means that roughly $500MM in annual sales will be achieved if Avonex plateaus right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next